Word: merck
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
Hidden Costs. Upset by the fast attack, Schering's President Francis C. Brown hotly protested that Keef's chart -and the Keef himself-were all wrong. Prednisolone, said Brown, is a Schering improvement on Merck & Co.'s basic cortisone, is marketed by Schering under the trade name Meticortelone. Schering cross-licensed other companies to make it and bought a lot of it from Upjohn Co., at $1.19 per hundred tablets. But this price, argued Brown, did not take into account the costs for research, administration, taxes, selling and distribution. By Schering's figuring, said Brown...
...Seymour N. Blackman, executive secretary of Premo Pharmaceutical Laboratories of South Hackensack, NJ. Blackman estimated that the U.S. public could save $750 million a year if physicians would use scientific instead of brand names in prescriptions. This year Premo sold the Government prednisone tablets at $20.01 per thousand, while Merck & Co. offered to supply them to the Government at $63.70 per thousand and sold them to druggists at $179, for a retail price...
When the subcommittee asked Merck & Co.'s President John T. Connor for an explanation, he was well prepared. The big companies, said he have different selling costs for individual sales and bulk sales to Government, could not stay in business if they sold to everybody at the same price. Connor turned out to be such an expert witness that Kefauver complained : "Every time I ask you a question you start reading." Replied Connor, who had 22 assistants with him and had spent six months getting ready to testify: "I thought I would do you the honor of coming well...
...cases a year) Addison's disease. In the search it found out, in 1949, how to mass-produce cortisone, today used by millions, and with its derivatives the most broadly prescribed chemical compound for disorders from arthritis to asthma and hay fever. Instead of profiteering, Connor said, Merck cut the price from $200 to $20 a gram before it had a competitor, then licensed so many other manufacturers that last year it had but 17% of the cortisone group market. Not for seven years did Merck recover its $21.8 million investment. Present to support Connor...
...Reason : spurts and lags in public demand have bedeviled the vaccine makers. Last year Eli Lilly & Co. alone destroyed n million doses for lack of takers (the vaccine deteriorates after six months). This year the U.S. Public Health Service has asked manufacturers to cut out exports. Both Lilly and Merck Sharp & Dohme laboratories have stepped up output; U.S. production to date (from five manufacturers) is up to more than 50 million doses-10% ahead of last year. But last week, with the belated demand for shots running ahead of estimates, North Carolina was out of vaccine. Rated as distressed areas...